Director Share Dealings

September 30, 2013

Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that today Ordinary Shares (“Shares”) and American Depository Shares (“ADSs”) of the Company, as set out below, have been acquired for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from July 1 to September 30, 2013.

 

 

Type of Security (1)

Number of Shares/ADSs

William Burns

Shares

247

 

Dr. Steven Gillis

ADSs

78

 

Dr. David Ginsburg

ADSs

79

 

David Kappler

Shares

212

 

Susan Kilsby

ADSs

84

 

Anne Minto

Shares

187

 

David Stout

ADSs

79

 

 

 

(1)    One ADS is equal to three Shares

The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively at prices of £24.85 per Share and $119.89 per ADS.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary

 

For further information please contact:

Investor Relations       

Eric Rojas   
erojas@shire.com
+1 781 482 0999

Sarah Elton-Farr  
+44 1256 894157

 

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

www.shire.com

 
Click here for the PDF version of this press release.